Effect of Lee Silverman Voice Treatment (LSVT)® BIG on motor symptoms in a patient with severe Parkinson's disease: a case report.

Lee Silverman Voice Treatment® big Severe Parkinson’s disease motor symptom

Journal

Physiotherapy theory and practice
ISSN: 1532-5040
Titre abrégé: Physiother Theory Pract
Pays: England
ID NLM: 9015520

Informations de publication

Date de publication:
Nov 2022
Historique:
pubmed: 15 6 2021
medline: 23 11 2022
entrez: 14 6 2021
Statut: ppublish

Résumé

Lee Silverman Voice Treatment® BIG (LSVT® BIG) is widely used to improve motor symptoms in patients with mild-to-moderate Parkinson's disease (PD). To describe the effect of LSVT® BIG on the motor symptoms of a patient with severe PD. A 77-year-old woman who was diagnosed with PD received a 4-week LSVT® BIG program under the supervision of certified LSVT® BIG physical therapists. Her disease severity was classified as Hoehn and Yahr stage 4. The unified Parkinson's disease rating scale (UPDRS) part 3, 10-m walk test (10MWT), timed up-and-go test (TUG), Berg balance scale (BBS), and 30-s chair stand test (30-s CST) were used for assessment before and after intervention. The UPDRS part 3, 10MWT, TUG, BBS, and 30-s CST improved after intervention (33 to 26, 0.51 to 0.69 m/s, 38.1 to 23.2 seconds, 11 to 34, and 3 to 9 times, respectively). All improvements exceeded the Minimal Clinically Important Difference or Minimal Detectable Change values (2.5, 0.16 m/s, 3.5 seconds, 5, and 3 times, respectively). These results indicated that LSVT® BIG appears to have improved motor symptoms in a patient with severe PD. Further studies, ideally randomized controlled trials, are needed to confirm these findings.

Identifiants

pubmed: 34125001
doi: 10.1080/09593985.2021.1938304
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3159-3168

Auteurs

Yuichi Hirakawa (Y)

Department of Rehabilitation, Kawamura Hospital, Gifu, Japan.
Graduate School of Health Sciences, Fujita Health University, Toyoake, Japan.

Kazuya Takeda (K)

Department of Rehabilitation, Kawamura Hospital, Gifu, Japan.

Soichiro Koyama (S)

Faculty of Rehabilitation, School of Health Sciences, Fujita Health University, Toyoake, Japan.

Yuki Naoi (Y)

Department of Rehabilitation, Kawamura Hospital, Gifu, Japan.

Tetsuro Matsushita (T)

Department of Rehabilitation, Kawamura Hospital, Gifu, Japan.

Tomoko Nagai (T)

Department of Rehabilitation, Kawamura Hospital, Gifu, Japan.

Ikuo Motoya (I)

Department of Rehabilitation, Kawamura Hospital, Gifu, Japan.

Hiroaki Sakurai (H)

Faculty of Rehabilitation, School of Health Sciences, Fujita Health University, Toyoake, Japan.

Yoshikiyo Kanada (Y)

Faculty of Rehabilitation, School of Health Sciences, Fujita Health University, Toyoake, Japan.

Nobutoshi Kawamura (N)

Department of Neurology, Kawamura Hospital, Gifu, Japan.

Mami Kawamura (M)

Department of Neurology, Kawamura Hospital, Gifu, Japan.

Shigeo Tanabe (S)

Faculty of Rehabilitation, School of Health Sciences, Fujita Health University, Toyoake, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH